Cargando…

Brachial Artery Vasospasm From Sequential Use of Intravenous Promethazine and Dihydroergotamine for Treatment of Status Migrainosus: A Case Report

Promethazine, a common antiemetic, can cause severe tissue injury with intravenous (IV) injection. Dihydroergotamine (DHE), commonly used for the acute treatment of migraine, can cause arterial vasoconstriction. We report a rare complication of brachial artery vasospasm in a patient receiving IV pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johns, Christopher, Ardakani, Rumyar, Das, Rohit R., Friedman, Deborah I., Frolov, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091437/ https://www.ncbi.nlm.nih.gov/pubmed/37064942 http://dx.doi.org/10.1177/19418744231153478

Ejemplares similares

Dihydroergotamine Complicating Reversible Cerebral Vasoconstriction Syndrome in Status Migrainosus
por: Mullaguri, Naresh, et al.
Publicado: (2018)

Role of intravenous levetiracetam in status migrainosus
por: Farooq, Muhammad U., et al.
Publicado: (2007)

Tozinameran: Status migrainosus: case report
Publicado: (2022)

Status migrainosus as an initial presentation of multiple sclerosis
por: Alroughani, Raed, et al.
Publicado: (2015)

Fatal status migrainosus in Chiari 1 malformation
por: Jokonya, Luxwell, et al.
Publicado: (2019)

Management of intraoperative hiccups with intravenous promethazine
por: Prakash, Smita, et al.
Publicado: (2013)

Reply to: Management of intraoperative hiccups with intravenous promethazine
por: Beyaz, Serbülent Gökhan
Publicado: (2014)

CADASIL presenting as status migrainosus and persisting aura without infarction
por: Sacco, Simona, et al.
Publicado: (2008)

Status Migrainosus and Endometriosis: A Case Report and Review of the Literature
por: Frankel, Lexi R, et al.
Publicado: (2021)

Persistent aura and status migrainosus in CADASIL syndrome: A case report
por: Hamid, Mohamed, et al.
Publicado: (2022)

Sumatriptan and dihydroergotamine in proximal and distal human isolated coronary arteries
por: Labruijere, S, et al.
Publicado: (2013)

Short Term Oral Methylergonovine Maleate Prophylaxis for Status Migrainosus. Case Series and Review of Literature
por: Haque, Najiya, et al.
Publicado: (2019)

Status migrainosus inpatient treatment with eptinezumab (SMITE): study protocol for a randomised controlled trial
por: Ray, Jason Charles, et al.
Publicado: (2022)

Aprepitant for the management of nausea with inpatient IV dihydroergotamine
por: Chou, Denise E., et al.
Publicado: (2016)

Dihydroergotamine (DHE) – Then and Now: A Narrative Review
por: Silberstein, Stephen D., et al.
Publicado: (2019)

Contractile responses to ergotamine and dihydroergotamine in the perfused middle cerebral artery of rat
por: Tfelt-Hansen, Peer, et al.
Publicado: (2007)

Coronary vasospasm induced by painful compression of the brachial artery following coronary angiography
por: Kraaijeveld, A. O., et al.
Publicado: (2013)

Risk and Predisposing Factors for Suicide Attempts in Patients with Migraine and Status Migrainosus: A Nationwide Population-Based Study
por: Harnod, Tomor, et al.
Publicado: (2018)

Assessing acute systemic effects of an inhaled drug with serial echocardiography: a placebo-controlled comparison of inhaled and intravenous dihydroergotamine
por: Noveck, Robert J, et al.
Publicado: (2013)

Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache
por: Robbins, Nathaniel M., et al.
Publicado: (2016)

Efficacy of promethazine suppositories dispensed to outpatient surgical patients.
por: Wright, C. D., et al.
Publicado: (1998)

Tics induced by promethazine in an adolescent: a case report
por: Akinsiku, Fiyinfoluwa
Publicado: (2021)

Effect of promethazine in cleft surgeries among Indian children
por: A, Vedha Vivigdha, et al.
Publicado: (2023)

Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations
por: Shafqat, Rafia, et al.
Publicado: (2020)

Dihydroergotamine and triptan use to treat migraine during pregnancy and the risk of adverse pregnancy outcomes
por: Bérard, Anick, et al.
Publicado: (2021)

Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action
por: Cooper, Wade, et al.
Publicado: (2022)

Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV-2 Infection
por: Stagnoli, Soledad, et al.
Publicado: (2023)

A Phase 1, Randomized, Open‐Label, Safety, Tolerability, and Comparative Bioavailability Study of Intranasal Dihydroergotamine Powder (STS101), Intramuscular Dihydroergotamine Mesylate, and Intranasal DHE Mesylate Spray in Healthy Adult Subjects
por: Albrecht, Detlef, et al.
Publicado: (2020)

Aneurysm of Brachial Artery Following Axillary Crutch
por: Vahedian-Ardakani, J, et al.
Publicado: (2011)

First chemoenzymatic stereodivergent synthesis of both enantiomers of promethazine and ethopropazine
por: Borowiecki, Paweł, et al.
Publicado: (2014)

Topical Promethazine Side Effects: Our Experience and Review of the Literature
por: Cantisani, C., et al.
Publicado: (2013)

Management of Brachial Artery Pseudoaneurysms in Intravenous Drug Abusers
por: Rehman, Khalil Ur, et al.
Publicado: (2020)

Neuropeptide release from slices of rat and guinea pig trigeminal ganglia: modulation by dihydroergotamine and sumatriptan
por: Tognetto, Michele, et al.
Publicado: (2000)

Dihydroergotamine ameliorates liver fibrosis by targeting transforming growth factor β type II receptor
por: Zheng, Ke-Xin, et al.
Publicado: (2023)

Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine—a case report
por: Consoli, Stefano, et al.
Publicado: (2021)

Coronary Artery Vasospasm
por: Song, Jae-Kwan
Publicado: (2018)

Formulation of sublingual promethazine hydrochloride tablets for rapid relief of motion sickness
por: Alyami, Hamad S, et al.
Publicado: (2021)

Promethazine hydrochloride reduces children’s agitation during ocular examination for trauma
por: Ghiasi, Zahra, et al.
Publicado: (2022)

The use of intravenous Milrinone to treat cerebral vasospasm following traumatic subarachnoid hemorrhage
por: Lasry, Oliver, et al.
Publicado: (2014)

Early Angiographic Resolution of Cerebral Vasospasm with High Dose Intravenous Milrinone Therapy
por: Zeiler, F. A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8ih1qnpa93p3lqhnltf60rn08n